Search

Search Constraints

You searched for: Author/Creator Fernandes, Laura L.

Search Results

2. FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin‐Containing Chemotherapy. (12th December 2018)